{"id":386603,"date":"2020-11-23T08:03:29","date_gmt":"2020-11-23T13:03:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386603"},"modified":"2020-11-23T08:03:29","modified_gmt":"2020-11-23T13:03:29","slug":"chiasma-to-participate-in-two-investor-conferences-in-december","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/","title":{"rendered":"Chiasma to Participate in Two Investor Conferences in December"},"content":{"rendered":"
\n

NEEDHAM, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful injections, today announced that management will be presenting and participating in investor meetings at both the Piper Sandler Healthcare Conference as well as the Evercore ISI HealthCONx Conference. Details for each conference are as follows:<\/p>\n\n\n\n\n\n
\n Piper Sandler Healthcare Conference:<\/strong>\n <\/td>\n<\/tr>\n
Date:<\/td>\nMonday, November 23, 2020 *<\/td>\n<\/tr>\n
Time:<\/td>\n10:00am ET<\/td>\n<\/tr>\n
Format:<\/td>\nFireside Chat<\/td>\n<\/tr>\n<\/table>\n

\n * <\/em>
\n All presentations for the Piper Sandler Healthcare Conference <\/em>
\n will be available on Piper<\/em>
\n Sandler\u2019s<\/em>
\n conference portal at 10<\/em>
\n :00 <\/em>
\n am on Monday, November 23.<\/em>
\n Actual dates<\/em>
\n for the conference<\/em>
\n are November 30 \u2013 December 3. <\/em>\n <\/p>\n\n\n\n\n\n
\n Evercore ISI HealthCONx Conference<\/strong>:<\/td>\n<\/tr>\n
Date:<\/td>\nThursday, December 3, 2020<\/td>\n<\/tr>\n
Time:<\/td>\n1:00pm ET<\/td>\n<\/tr>\n
Format:<\/td>\nPanel Discussion, \u201cEasy Pills to Swallow: Oral Drugs for Large Endo Markets\u201d – Chiasma, Crinetics and Lumos<\/td>\n<\/tr>\n<\/table>\n

A live audio webcast of each of the two events may be accessed under \u201cEvents & Presentations\u201d on the News and Investors section of Chiasma\u2019s website at\u00a0https:\/\/ir.chiasma.com\/events-presentations<\/a>. A replay will be available for 90 days.<\/p>\n

\n About Chiasma
<\/strong>Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE\u00ae) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. On June 26, 2020, Chiasma received FDA approval of MYCAPSSA for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA, the first and only oral somatostatin analog approved by the FDA, is available for commercial sale in the United States. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma. For more information, please visit the company\u2019s website at www.chiasma.com<\/a>.<\/p>\n

\n Investor Relations and Corporate Communications:<\/strong>
\n
Ashley Robinson
LifeSci Advisors, LLC
617-430-7577
arr@lifesciadvisors.com<\/a><\/p>\n

\n Media Relations:<\/strong>
\n
Patrick Bursey
LifeSci Communications
646-876-4932
pbursey@lifescicomms.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEEDHAM, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful injections, today announced that management will be presenting and participating in investor meetings at both the Piper Sandler Healthcare Conference as well as the Evercore ISI HealthCONx Conference. Details for each conference are as follows: Piper Sandler Healthcare Conference: Date: Monday, November 23, 2020 * Time: 10:00am ET Format: Fireside Chat * All presentations for the Piper Sandler Healthcare Conference will be available on Piper Sandler\u2019s conference portal at 10 :00 am on Monday, November 23. Actual dates for the … <\/p>\n

Continue reading “Chiasma to Participate in Two Investor Conferences in December”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386603","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nChiasma to Participate in Two Investor Conferences in December - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chiasma to Participate in Two Investor Conferences in December - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEEDHAM, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful injections, today announced that management will be presenting and participating in investor meetings at both the Piper Sandler Healthcare Conference as well as the Evercore ISI HealthCONx Conference. Details for each conference are as follows: Piper Sandler Healthcare Conference: Date: Monday, November 23, 2020 * Time: 10:00am ET Format: Fireside Chat * All presentations for the Piper Sandler Healthcare Conference will be available on Piper Sandler\u2019s conference portal at 10 :00 am on Monday, November 23. Actual dates for the … Continue reading "Chiasma to Participate in Two Investor Conferences in December"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-23T13:03:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Chiasma to Participate in Two Investor Conferences in December\",\"datePublished\":\"2020-11-23T13:03:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/\"},\"wordCount\":355,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/\",\"name\":\"Chiasma to Participate in Two Investor Conferences in December - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==\",\"datePublished\":\"2020-11-23T13:03:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chiasma-to-participate-in-two-investor-conferences-in-december\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chiasma to Participate in Two Investor Conferences in December\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chiasma to Participate in Two Investor Conferences in December - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/","og_locale":"en_US","og_type":"article","og_title":"Chiasma to Participate in Two Investor Conferences in December - Market Newsdesk","og_description":"NEEDHAM, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful injections, today announced that management will be presenting and participating in investor meetings at both the Piper Sandler Healthcare Conference as well as the Evercore ISI HealthCONx Conference. Details for each conference are as follows: Piper Sandler Healthcare Conference: Date: Monday, November 23, 2020 * Time: 10:00am ET Format: Fireside Chat * All presentations for the Piper Sandler Healthcare Conference will be available on Piper Sandler\u2019s conference portal at 10 :00 am on Monday, November 23. Actual dates for the … Continue reading \"Chiasma to Participate in Two Investor Conferences in December\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-23T13:03:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Chiasma to Participate in Two Investor Conferences in December","datePublished":"2020-11-23T13:03:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/"},"wordCount":355,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/","name":"Chiasma to Participate in Two Investor Conferences in December - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==","datePublished":"2020-11-23T13:03:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDI2NyMzODM4NjM3IzUwMDA3MTQ2Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chiasma-to-participate-in-two-investor-conferences-in-december\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Chiasma to Participate in Two Investor Conferences in December"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386603"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386603\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}